CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 5 of 48

Rheumatology (Oxford)

Briefs 161–200 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    Whole body-MRI identifies widespread, low intensity inflammation in peripheral joints, and axial involvement in a third of patients with early, treatment-naïve, active PsA: data from the GOLMePsA clinical trial

    Secondary analysisSpondyloarthritis & PsA

  2. Rheumatology (Oxford)

    Risk of chronic kidney disease in newly diagnosed SLE with preserved renal function: a national study

    Cohort studyLupus & APS

  3. Rheumatology (Oxford)

    Concordance for myositis-specific autoantibody detection between commercial ELISA and line blot assays: a multicentre study conducted across the Asia-Pacific region

    Diagnostic or prognostic studyMyositis

  4. Rheumatology (Oxford)

    From disability to daily life: functional status, quality of life and work productivity in real-world inflammatory arthritis

    Cross-sectional studyRA

  5. Rheumatology (Oxford)

    Prevalence and prognostic value of activated protein C resistance and anti–protein C antibodies in patients with aPLs: an APS ACTION Registry study

    Cohort studyLupus & APS

  6. Rheumatology (Oxford)

    Association between biologic exposure and relapse incidence in relapsing polychondritis: a retrospective cohort study

    Cohort studyAutoinflammatory & rare

  7. Rheumatology (Oxford)

    Scleroderma calcinosis cutis score (SC2S): an imaging metric to quantify SSc-calcinosis cutis

    Research articleSystemic sclerosis

  8. Rheumatology (Oxford)

    Body mass index and achievement of minimal disease activity in psoriatic arthritis across different classes of advanced therapy

    Cohort studySpondyloarthritis & PsA

  9. Rheumatology (Oxford)

    T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practice

    Mechanistic studyRA

  10. Rheumatology (Oxford)

    Changes in systemic medication in children and adolescents with JIA: why, when and which patterns

    Cohort studyPediatric

  11. Rheumatology (Oxford)

    Patient–physician discordance in idiopathic inflammatory myopathies: a longitudinal analysis of links to disease activity and damage

    Cohort studyMyositis

  12. Rheumatology (Oxford)

    Lifetime risk of malignancy in polymyalgia rheumatica: a population-based matched cohort study from southern Norway

    Cohort studyVasculitis & PMR

  13. Rheumatology (Oxford)

    Comparative effectiveness and safety of sarilumab vs JAK inhibitors in late- and younger-onset rheumatoid arthritis

    Cohort studyRA

  14. Rheumatology (Oxford)

    Prospective evaluation of recombinant Herpes zoster vaccine in SSc: immunogenicity, safety and disease outcomes

    Secondary analysisSystemic sclerosis

  15. Rheumatology (Oxford)

    Malignancy rates in children, young people and adults with JIA: an observational study using CPRD Aurum

    Cohort studyPediatric

  16. Rheumatology (Oxford)

    Development of a mobile health application to support the management of paediatric FMF

    Cohort studyPediatric

  17. Rheumatology (Oxford)

    Detecting inflammatory arthritis in hand smartphone photographs: development and validation of a computer vision model in clinical settings

    Diagnostic or prognostic studyRA

  18. Rheumatology (Oxford)

    Prevalence and characteristics of subclinical polymyalgia rheumatica in patients with giant cell arteritis

    Cohort studyVasculitis & PMR

  19. Rheumatology (Oxford)

    Cycling versus swapping strategies for treatment of psoriatic arthritis after primary tumour necrosis factor inhibitors failure: a systematic review and meta-analysis

    Meta-analysisSpondyloarthritis & PsA

  20. Rheumatology (Oxford)

    Pneumonia and in-hospital mortality in ANCA-associated vasculitis: a nationwide population-based registry study in Spain

    Cohort studyVasculitis & PMR

  21. Rheumatology (Oxford)

    Early belimumab accelerates renal response and reduces glucocorticoid exposure in lupus nephritis: a multicentre propensity-matched study

    Cohort studyLupus & APS

  22. Rheumatology (Oxford)

    Incorporating frailty and disease severity into treatment decisions for older patients with ANCA-associated vasculitis

    Cohort studyVasculitis & PMR

  23. Rheumatology (Oxford)

    Reduced follicular helper T cells in peripheral blood marks a distinct feature of retroperitoneal fibrosis

    Mechanistic studyAutoinflammatory & rare

  24. Rheumatology (Oxford)

    Risk-updating nomogram for refractory systemic JIA in children: multicentre development and external validation

    Diagnostic or prognostic studyPediatric

  25. Rheumatology (Oxford)

    One-month delay in MTX initiation on RA outcomes: 1-year ancillary analysis of the VACIMRA trial

    Randomized controlled trialRA

  26. Rheumatology (Oxford)

    The clinical utility of telangiectasia quantification as markers of vascular disease progression in systemic sclerosis

    Cross-sectional studySystemic sclerosis

  27. Rheumatology (Oxford)

    Repair of radiographic joint damage in psoriatic arthritis: a cohort study

    Cohort studySpondyloarthritis & PsA

  28. Rheumatology (Oxford)

    Early gastrointestinal manifestations predict disease progression and mortality in patients with systemic sclerosis

    Cohort studySystemic sclerosis

  29. Rheumatology (Oxford)

    Prevalence of foot/ankle osteoarthritis and pain in retired male professional footballers compared with general population male controls: a cross-sectional study

    Cross-sectional studyOsteoarthritis

  30. Rheumatology (Oxford)

    Before calling it FMF: MEFV variants of uncertain significance in autoinflammatory disease

    Cohort studyPediatric

  31. Rheumatology (Oxford)

    Predictive correlates of arthritis and joint damage in systemic lupus erythematosus: a multinational prospective cohort study

    Cohort studyLupus & APS

  32. Rheumatology (Oxford)

    Impact of comorbidities and extra-musculoskeletal manifestations on radiographic progression in ankylosing spondylitis

    Cohort studySpondyloarthritis & PsA

  33. Rheumatology (Oxford)

    Circulatory microRNA signature distinguishing rheumatoid arthritis and psoriatic arthritis

    Cross-sectional studyRA

  34. Rheumatology (Oxford)

    Higher hydroxychloroquine dose based on actual body weight is associated with lower SLE flare risks while maintaining tolerability

    Cohort studyLupus & APS

  35. Rheumatology (Oxford)

    Second delivery rates and recurrence of adverse pregnancy outcomes in women with systemic lupus erythematosus: a nationwide population-based cohort study

    Cohort studyLupus & APS

  36. Rheumatology (Oxford)

    Patient-reported outcomes and disease activity in giant cell arteritis: a longitudinal registry-based study

    Cohort studyVasculitis & PMR

  37. Rheumatology (Oxford)

    Risk of interstitial lung disease following COVID-19 infection in patients with autoimmune diseases: a retrospective cohort study

    Cohort studyAcross diseases

  38. Rheumatology (Oxford)

    Autoantibody reactome analysis reveals novel biomarkers for idiopathic retroperitoneal fibrosis

    Diagnostic or prognostic studyAutoinflammatory & rare

  39. Rheumatology (Oxford)

    Outcomes with transcatheter aortic valve replacement for aortic stenosis in rheumatoid arthritis: an observational study

    Cohort studyRA

  40. Rheumatology (Oxford)

    Single-cell profiling reveals CCL5Hi GZMAHi effector memory CD8 T cell association to oligoarticular JIA

    Mechanistic studyPediatric

All 1,905 Briefs in ExploreShowing Briefs 161–200 of 1,905, newest first